Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269
What this trial is testing

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Who this might be right for
Malignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more
M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00350597
What this trial is testing

GM-CSF as Adjuvant Therapy of Melanoma

Who this might be right for
Malignant Melanoma
Northern California Melanoma Center 50
Testing effectiveness (Phase 2)Study completedNCT00026520
What this trial is testing

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT01851824
What this trial is testing

The Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 9
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Not applicableStudy completedNCT03682562
What this trial is testing

Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions

Who this might be right for
Oral CancerOral Lichen PlanusOral Leukoplakia
Cairo University 93
Large-scale testing (Phase 3)Active Not RecruitingNCT04949113
What this trial is testing

Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 423
Testing effectiveness (Phase 2)Active Not RecruitingNCT00539591
What this trial is testing

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Who this might be right for
Malignant Melanoma
St. Jude Children's Research Hospital 29
Testing effectiveness (Phase 2)Study completedNCT02158520
What this trial is testing

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
Academic and Community Cancer Research United 24
Testing effectiveness (Phase 2)Study completedNCT02574260
What this trial is testing

An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)

Who this might be right for
Melanoma
BioVex Limited 3
Not applicableActive Not RecruitingNCT07415291
What this trial is testing

CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis

Who this might be right for
Solitary Skin LesionsSkin NeoplasmsSkin Neoplasm Malignant
Istanbul Training and Research Hospital 17,625
Testing effectiveness (Phase 2)Ended earlyNCT00560118
What this trial is testing

Fotemustine in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Institut du Cancer de Montpellier - Val d'Aurelle 12
Not applicableLooking for participantsNCT04493723
What this trial is testing

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

Who this might be right for
Melanoma
The Christie NHS Foundation Trust 300
Testing effectiveness (Phase 2)Study completedNCT00299689
What this trial is testing

Phase II Trial of Ontak With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
James Graham Brown Cancer Center 69
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Not applicableUnknownNCT02408835
What this trial is testing

Negative Pressure Wound Therapy in Groin Dissection

Who this might be right for
Neoplasm MetastasisSecondary Malignant Neoplasm of Lymph NodeNon-healing Surgical Wound (Disorder)+1 more
South Eastern Health and Social Care Trust 22
Testing effectiveness (Phase 2)Study completedNCT00715793
What this trial is testing

Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hussein Tawbi 39
Next Page